Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21 USD | +11.29% | +5.69% | -1.96% |
04-16 | Leerink Partners Starts AnaptysBio With Outperform Rating, $47 Price Target | MT |
04-11 | Wells Fargo Initiates AnaptysBio With Overweight Rating, $56 Price Target | MT |
Sales 2024 * | 16.39M 1.31B | Sales 2025 * | 25.59M 2.05B | Capitalization | 574M 45.93B |
---|---|---|---|---|---|
Net income 2024 * | -178M -14.25B | Net income 2025 * | -196M -15.69B | EV / Sales 2024 * | 17.7 x |
Net cash position 2024 * | 283M 22.66B | Net cash position 2025 * | 316M 25.28B | EV / Sales 2025 * | 10.1 x |
P/E ratio 2024 * |
-3.32
x | P/E ratio 2025 * |
-3.58
x | Employees | 117 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.61% |
Latest transcript on AnaptysBio, Inc.
1 day | +11.29% | ||
1 week | +5.69% | ||
Current month | -6.75% | ||
1 month | -2.78% | ||
3 months | -11.05% | ||
6 months | +23.67% | ||
Current year | -1.96% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Faga
CEO | Chief Executive Officer | 44 | 25/11/21 |
Dennis Mulroy
DFI | Director of Finance/CFO | 69 | 14/07/20 |
Paul Lizzul
CTO | Chief Tech/Sci/R&D Officer | 49 | 30/07/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hollings Renton
BRD | Director/Board Member | 77 | 29/06/15 |
Dennis Fenton
BRD | Director/Board Member | 72 | 04/03/18 |
Magda Marquet
BRD | Director/Board Member | 65 | 17/01/21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.02% | 509 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 21 | +11.29% | 649,412 |
25/04/24 | 18.87 | -2.08% | 401,012 |
24/04/24 | 19.27 | +0.47% | 385,671 |
23/04/24 | 19.18 | -2.44% | 387,321 |
22/04/24 | 19.66 | -1.06% | 139,714 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.96% | 574M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ANAB Stock